Category: Pharmaceutical

Categories
Pharmaceutical

Adoption of Biochips To Improve Disease Diagnosis To Propel The Medical Textiles & Wound Dressing Sales | Report Fact.MR

Increasing demand for advanced and effective equipment and favorable government initiatives are expected to drive the nano healthcare technology market, finds Fact.MR in a new study. The increasing geriatric population along with developments in the healthcare sector are key drivers of the market. Increasing government initiatives and investments are primary factors that are encouraging the adoption of nanotechnology in healthcare.

The advent of nano technology has helped in enhancing and improving various healthcare systems and is creating opportunities to transform various processes within the healthcare industry, including diagnosis, treatment, drug delivery, and others. Incorporating nano technology in monitoring devices, imaging, and bioassay ensures improved accuracy in disease diagnosis.

There has been increasing adoption of nano technology in the treatment of chronic diseases. It finds application in biochips, implantable materials and medical textile, and wound dressing. The growing number of patients affected by COVID-19 also has affected the market growth.

Request a report sample to gain comprehensive market insights at

https://www.factmr.com/connectus/sample?flag=S&rep_id=5430

Key Takeaways from Nano Healthcare Technology Market Report

  • There has been an increase in adoption of biochips to improve disease diagnosis, which is aiding the sales uptick in nano healthcare technology market.
  • High costs and complex product approval procedures however might restrict demand to a certain extent
  • North America will emerge as a dominant market as the region exhibits high investment in modern healthcare. Asia Pacific too will offer lucrative growth opportunities through the forecast period
  • The demand for active implantable devices is poised to surge exponentially in the coming years, creating attractive opportunities for growth
  • In the coming years, therapeutic application of nano healthcare technology will rise significantly, finds Fact MR in a study

“Demand for advanced treatment processes will continue rising as the healthcare sector witnesses a surge in incidence of chronic ailments. Technological improvements are highly sought-after, now more than ever before, especially as countries around the world try containing the spread of the novel coronavirus. Nano-technology is believed to have potential for enabling early detection of COVIDF-19 even before a patient starts showing symptoms. In the coming years, its penetration across the healthcare sector is likely to surge considerably,” said a lead analyst at Fact MR.

Speak to Research Analyst

https://www.factmr.com/connectus/sample?flag=AE&rep_id=5430

COVID-19 Impact on Nano Healthcare Technology Market

The COVID-19 pandemic has disrupted several industries including the nano healthcare technology market. The implementation of lockdown and transport bans have affected the production of equipment. But the increasing number of patients has positively affected demand for nano technology based devices.

The market is expected to recover from the pandemic at a moderate growth rate. Increasing caution regarding health is expected to increase the use of nano technology based devices in the healthcare industry.

Competitive Landscape of Nano Healthcare Technology Market

Players operating in the market are now focusing on the research and development of nano technology to improve its efficiency across diverse applications. Developments underway to improve drug delivery and ensure better accuracy in diagnosis.

Nano Technology is now being used to develop smart pills that will increase treatment efficiency. Special nano bots are also being introduced to assist and conduct various surgeries. There have been major concerns regarding the side effects and deficiencies of using nano technology due to the less research conducted. Players are focusing on dispelling these doubts by increasing experimentation and research.

For instance, researchers at Massachusetts Institute of Technology, Draper, and Brigham and Women’s Hospital have unveiled the design of an ingestible capsule that can be controlled using wireless technology – Bluetooth. The design of this capsule can be customized to sense environmental conditions, deliver drugs, and live in stomach for nearly a month, transmitting information to users and responding to instructions they share via smartphones.

Full Access of this Report Is Available at

https://www.factmr.com/checkout/5430

Some of the key players in the nano healthcare technology market are

3M Company
Thermo Fisher Scientific Inc.
Smith & Nephew Plc.
GE Global Research
Greiner Bio One International GmbH
Dentsply Sirona
Ferro Corporation
Boston Scientific Corporation
Sonova
LivaNova Plc.
Abbott Laboratories
Stryker Corporation
Merck KGaA
Demant A/S
Eppendorf AG
Medtronic
Cochlear Ltd.

For More Insights https://www.biospace.com/article/canine-influenza-treatment-demand-driven-by-high-unmet-requirement-for-treatment-of-canine-flu-says-fact-mr

Key Questions Answered in Fact.MR’s Nano Healthcare Technology Market Report

  • Which regions will continue to remain the most profitable regional markets for nano healthcare technology market players?
  • Which factors will induce a change in the demand for nano healthcare technology during the assessment period?
  • How will changing trends impact the nano healthcare technology market?
  • How can market players capture the low-hanging opportunities in the nano healthcare technology market in developed regions?
  • Which companies are leading the nano healthcare technology market?
  • What are the winning strategies of stakeholders in the nano healthcare technology market to upscale their position in this landscape?

Valuable Insights into Nano Healthcare Technology Market Report

In its latest report, Fact.MR has presented a detailed analysis of the nano healthcare technology market along with an assessment for the years 2020-2030. In order to provide a better understanding, the market has been divided into several segments.

The market has been segmented based on the product into biochips, implantable materials, medical textile & wound dressing, active implantable devices and others. On the basis of application, the market has been divided into therapeutic applications, diagnostic applications and research applications. The market is segmented based on geography into North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Rising Adoption of Biopharmaceuticals In Healthcare Boost Nucleic Acid Detection Kits | Report Fact.MR

Biopharmaceuticals and pharmaceutical companies are adopting several contamination detection techniques during manufacturing and research process. Mycoplasma detection is gaining significant adoption in contamination testing in cell culture, tissue culture, and purified biologics. Techniques such as real-time PCR is fast and reliable and gaining significant demand in research and development or for in-process control during biopharmaceutical production.Moreover, growing pharmaceutical spending and R&D investment, and increasing production of biopharmaceuticals are some of the factors propelling the mycoplasma detection market growth. The global mycoplasma detection market is estimated to be valued at US$ 656.2 Bn in 2019.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=446

Key Segments of the Mycoplasma Detection Market

Fact.MR’s study on the mycoplasma detection market offers information divided into six important segments— product type, technique, end user and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product Type Technique End User Region
  • Kits & Reagents
    • PCR Assays
    • Nucleic Acid Detection Kits
    • Elimination Kits & Reagents
    • Others
  • Services
  • Systems
    • PCR Based Systems
    • Luminescence Based Systems
  • PCR
  • ELISA
  • Direct & Indirect Assay
  • Others
  • Pharmaceutical & Biopharmaceutical Companies
  • Research Laboratories
  • Contract Research Organizations (CROs)
  • Academic Research Institutes
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

For comprehensive insights on this market adoption, ask an analyst here – https://www.factmr.com/connectus/sample?flag=AE&rep_id=446

Key Takeaways of Mycoplasma Detection Market Study

  • By product type, kits & reagents are set to account for prominent market value share in the mycoplasma detection market with the growing usage of kits and reagents in mycoplasma detection for cell culture applications.
  • North America and Europe collectively hold over 58% of the global mycoplasma detection market share owing to growing research and production activities in biopharmaceutical industries.
  • Based on technique, PCR technique accounted for half of the market value share in the global mycoplasma detection market. PCR techniques are expected to grow with the highest growth rate owing to delivery of accurate and fast results associated with this technique.
  • Pharmaceutical & biopharmaceutical companies are expected to be the dominant end-user in the mycoplasma detection market. This is attributed to the higher R&D investments and greater demand for mycoplasma detection devices for biological safety management during production.
  • The ongoing COVID-19 pandemic shall provide increasing scope for the expansion of the mycoplasma detection market. A common ground for expansion is the specialization in PCR techniques. Recent research into the cures for the coronavirus suggests that quantitative real-time polymerase chain reaction (q RT-PCR) test is an important approach towards mitigating the spread of the disease. It is anticipated that the different PCR test techniques will be applicable both in mycoplasma detection as well as eradication of the current pandemic.

global mycoplasma detection market

“Introduction of real-time PCR kits, growing safety concern in biopharmaceutical production, and rise in life science investments & funding are some of the factors anticipated to favor the global mycoplasma detection market growth.” says the Fact.MR Analyst.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/446

Product Portfolio Expansion and Partnership are Key Strategies Followed by Market Players

Merck KgaA, Thermo Fisher Scientific Inc., Lonza Group Ltd., and F. Hoffmann-La Roche Ltd contributed higher market value share in global mycoplasma detection market. Mycoplasma detection manufacturers are focusing on the expansion of the product portfolio. For instance, in March 2019, Lonza introduced Lucetta 2 Luminometer, a single-tube mycoplasma detection system to simplify and speed up mycoplasma detection in cell cultures. Manufacturers are also focusing on partnership and agreement with other manufacturers to expand product sales. For instance, in December 2016 Merck KgaA announced an expansion of its distribution alliance with Roche for PCR products for all countries except the U.S., Brazil and Japan.

Why Choose Fact.MR?

  1. Deliver updated information on the current industry trends
  2. Available 24/7 to facilitate clients with unbiased solutions
  3. Embrace digital technologies to offer accurate business ideas
  4. Exhaustive supply chain augmentation analysis
  5. Provide reports strictly according to the requirements of the clients

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Sepsis Diagnostics Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031: https://www.factmr.com/report/391/sepsis-diagnostics-market

Ultrasound Systems Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031: https://www.factmr.com/report/60/ultrasound-systems-market

Blood Thawing System Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031: https://www.factmr.com/report/blood-thawing-system-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Rare Neurological Disease Treatment: Small Molecules Is Expected to Hold a Major Market Share With a CAGR 8.5%

The market for rare neurological disorder treatment is expected to follow an upward growth trend over the forecast period on the back of increasing trend of e-prescribed drugs, promotional programs and regulatory exclusivity. The new business model to invest more in orphan drugs developments could offer an integrated healthcare solution that enables pharmaceutical companies to develop newer areas of therapeutics, diagnosis, treatment, monitoring, and patient support. In addition, increasing penetration of online pharmacies is also becoming a wish list of key manufacturers to drive revenue in the rare neurological disease treatment market.

Click HERE To Get a SAMPLE (Including Full TOC, Table & Figures) at  https://www.factmr.com/connectus/sample?flag=S&rep_id=4594

Global Rare Neurological Disease Treatment Market: In-Depth Assessment on Key Segments

The global rare neurological disease treatment market is segmented on the basis of drug class, route of administration, disease indication, distribution channel, and region.

Drug Class
  • Anti-depressants
  • Anti-psychotics
  • Cholinesterase Inhibitors
  • Biologics
  • Others (Anti-vertigo, Anti-seizure, etc.)
Route of Administration
  • Injectable
  • Oral
Disease Indication
  • Alzheimer’s Diseases
  • Narcolepsy
  • Multiple Sclerosis
  • Amyotrophic Lateral Sclerosis
  • Others
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies and Drug Store
  • Online Pharmacies
Region
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Key Takeaways from the Rare Neurological Disease Treatment Market:

  • In terms of revenue, North America accounts for ~40% of the market share in the global rare neurological disease treatment market
  • In East Asia, three countries namely Japan, Taiwan and South Korea have introduced policies that foster orphan drug research and development. Resultantly, the region is expected to witness a strong growth of over 8% during the forecast period (2018-2028).
  • Increasing per capita healthcare spending on rare neurological diseases such as Alzheimer’s is supporting the robust growth of the global rare neurological disease treatment market. Healthcare spending on Alzheimer’s disease treatment is poised to create an absolute $ opportunity of more than US$ 5 Bn during the forecast period.
  • The retail pharmacy and drug store segment continues to set a high standard to achieve superior rates of customer satisfaction and is projected to grow at a Y-o-Y of 9% through the forecast period

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4594

“Strategic partnerships between pharmaceutical giants and researchers as well as orphan drug legislations are providing financial incentives for companies developing drugs for rare neurological diseases”, Says an Analyst at Fact.MR

Market Players Consolidating with Widening Investment Opportunities

The global rare neurological disease treatment market is consolidated across the legacy regions and witnessing several new investments and entry of new manufacturers in key therapeutic areas owing to increasing prevalence of rare diseases. Key Players such as Pfizer, Inc., Johnson & Johnson Services, Inc. and Novartis AG are continuously emphasizing on new investments and R&D activities to reduce their manufacturing costs. Over the years, the global market for rare neurological disease treatment has witnessed several collaborations and partnerships between the drug manufacturers to enhance revenue generation and expand geographical drug footprints. This has created several growth opportunities for manufacturers to increase their share in the rare neurological disease treatment market.

Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/4594

Looking for more information?

The research study on the rare neurological disease treatment market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends, which have shaped the landscape of the rare neurological disease treatment market over 2013 – 2017 and includes a detailed assessment of key parameters that are anticipated to exert influence during 2018 – 2028. Market statistics have been presented on the basis of drug class (anti-depressants, anti-psychotics, cholinesterase inhibitors, biologics, and others (anti-vertigo, anti-seizure, etc.)), route of administration (injectable and oral), disease indication (alzheimer’s disease, narcolepsy, multiple sclerosis, amyotrophic lateral sclerosis, and others), and distribution channel (hospital pharmacies, retail pharmacies & drug stores, and online pharmacies) across major countries of key regions.

Fact.MR’s Domain Knowledge in Healthcare

Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the healthcare sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support – encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions.

Why Choose Fact.MR?

  1. 24/7 Service Offering
  2. Digital Business Strategy Solutions
  3. Precise Supply Chain Augmentation Analysis
  4. Syndicated and Customized Reports for Clients
  5. Up-To-Date Insights on Industry Trends

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Predictive Diagnostics Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031: https://www.factmr.com/report/predictive-diagnostics-market

Circulating Tumor Cells (CTC) Diagnostics Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030: https://www.factmr.com/report/circulating-tumor-cells-ctc-diagnostics-market

Bacteriophage Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030: https://www.factmr.com/report/bacteriophage-market

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Content Source: https://www.factmr.com/media-release/1367/global-rare-neurological-disease-treatment-market

Categories
Pharmaceutical

Anaphylaxis Segment Currently Accounts For More Than 2/3rd Revenue Share of The Prefilled Auto Injectors Market

The arrival of an array of cutting-edge biotech products coupled with the increasing preference for convenient injection of various therapeutic drugs is making a positive impact on the global market for prefilled auto-injectors. According to the recent study conducted by Fact.MR, the global demand for prefilled auto injectors is set to ride at a double-digit CAGR during 2017 to 2022, to reach a valuation in excess of US$ 3,616 Mn.

Demand for such injectors is anticipated to further escalate over the next couple of years. Self-inject procedures have become safer and convenient due to availability of advanced prefilled auto-injectors. Patient are increasingly putting their trust on prefilled auto-injector owing to the product’s efficiency and credibility. Moreover, ongoing advancements in technology is leading towards constant improvement in prefilled auto-injector functionalities and capabilities.

In order to expand their application in new therapeutic areas, most device manufacturers are now emphasizing on further development of prefilled auto-injectors. The next prefilled auto-injectors are more accurate and reliable. Such leading-edge instruments are becoming widespread due to their functional superiority on conventional needles and syringes that can cause injuries.

To remain ‘ahead’ of your competitors, request for a sample https://www.factmr.com/connectus/sample?flag=S&rep_id=169

Forecast Highlights on the Global Market for Prefilled Auto-Injectors

North America is projected to retain its predominant position in the global market for prefilled auto-injectors over 2022. In addition, the region’s prefilled auto-injectors market is anticipated to register an impressive CAGR during the projection period.  This growth is mainly attributed to the expanding pool of patients who require drug administration on daily basis in the region.

Factors such as low cost of prefilled auto-injectors and quick expansion of the healthcare industry are influencing Asia-Pacific excluding Japan (APEJ)’s prefilled auto injection market. The market in APEJ is expected to surge at little under 16% CAGR between 2017 and 2022. Currently, Europe accounts for over 10% share of the market in terms of revenue and is expected to exhibit lucrative opportunities for market players in the near future.

On the basis of indication, use of prefilled auto-injection is significantly high for treating anaphylaxis indication. Towards the end of the forecast period, nearly US$ 3,200 Mn worth prefilled auto-injectors is estimated to be used for treating anaphylaxis.

Online pharmacies are the largest distribution channel for prefilled auto injectors. In terms of revenue, online pharmacies currently account for around 33% share of the market. By the end of 2022, the online pharmacies distribution channel segment is estimated to reach a valuation of nearly US$ 1,500 Mn, reflecting a healthy CAGR.

Speak To Research Analyst For Detailed Insights: https://www.factmr.com/connectus/sample?flag=AE&rep_id=169

Market Taxonomy

Indication
  • Anaphylaxis
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Others
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores

In order to offer readers with up-to-date information about the latest advancements in the global prefilled auto-injectors market, the report provides updates about market opportunities, which can benefit leading manufacturers of prefilled auto-injectors. With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for prefilled auto-injector manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided in this section.

The Fact.MR report provides segment-wise analysis and forecast for covering the wide scope of global prefilled auto-injectors market. Indication, distribution channel and region are key segments that define the growth of the global market for prefilled auto-injectors. In this segmentation analysis, a detailed country-wise forecast across all key market parameters is also included.

The report’s last section comprises of the global prefilled auto-injectors market competitive landscape, to provide readers with the dashboard view of company analysis and market players. This competitive intelligence is based on the providers’ categories across value chain, and their presence in the global prefilled auto-injectors market.

Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/169

Competition Tracking

  • Eli Lilly and Company
  • Becton
  • Dickinson and Company
  • Mylan N.V.
  • Amgen Inc.
  • Pfizer Inc.
  • Antares Pharma, Inc.

For More Insights https://www.prnewswire.com/news-releases/organic-hair-care-products-sales-surging-at-7-cagr-backed-by-consumer-preference-for-ingredients-derived-from-natural-sources-fact-mr-301325523.html

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Demand for Fully Automated Newborn Screening Instruments to Incline at over 8% CAGR, Globally | Report Fact.MR

Award-winning consulting firm Fact.MR’s recent report on the newborn screening market forecasts an optimistic outlook, predicting a CAGR surpassing 8% to reach a valuation of over US$ 1 billion by 2031. Increased spending on infant care in the wake of accelerating birth rates is principally driving demand for newborn screening solutions.

The market posted impressive gains in the past, expanding at under 8% CAGR from 2016 to 2020. Stakeholders have been inclining specifically towards the use of newborn screening consumables to predict highly accurate outcomes and growing hygiene concerns associated with reusable screening products.

For more insights into the Market, Request a Sample of this Report https://www.factmr.com/connectus/sample?flag=S&rep_id=6323

According to the World Health Organization, the world has seen a dramatic reduction to the tune of 60% in the under-five category, from 93 deaths per 1,000 live births in 1990 to 38 in 2019. However, global burden of child and youth death remains high, with over 7 million children, adolescents, and youth aged 0-14 years succumbing to preventable diseases. Consequently, governments across key regions are spending on improving existing infant care infrastructure, prompting the entry of key newborn screening solutions providers.

Key Takeaways from Market Study

  • By product, newborn screening consumables to expand impressively, growing at approximately 8% CAGR through 2031
  • Demand for newborn immunoassays & enzymatic screening tests to expand at nearly 7% CAGR over the next ten years
  • By test, dry blood spot tests to experience high demand, expanding at around 9% CAGR through 2031
  • The U.S. to open up positive expansion prospects, with the market likely to expand at approximately 5% CAGR from 2021 to 2031
  • Rising infant mortality rates to bolster growth prospects for India, expected to generate 30% of overall revenue
  • China to account for 50% of demand amid high uptake of congenital hypothyroidism (CH) and phenylketonuria (PKU) diagnosis

“High concentration of infant population across key emerging economies are attracting a plethora of newborn screening service providers across major countries, poised to generate new revenue streams in the future,” comments a Fact.MR analyst.

Get Customization on this Research Report for specific research solutions https://www.factmr.com/connectus/sample?flag=RC&rep_id=6323

Key Market Segments Covered

  • Product
    • Newborn Screening Instruments
      • Disorder Screening Instruments
        • Fully Automated Newborn Screening Instruments
        • Other Newborn Screening Instruments (Semi-automated Instruments, Shakers, Incubators, etc.)
      • Hearing Screening Instruments
        • Newborn Screening Accessories
        • Newborn Screening Devices
      • Pulse Oximeters
    • Consumables
      • Newborn Screening Assay Kits & Reagents
      • Other Newborn Screening Consumables (Columns and Screening Cards)
  • Test Type
    • Dry Blood Spot Newborn Screening Tests
    • Newborn Hearing Screening Tests
    • Critical Congenital Heart Disease (CCHD) Screening Tests
  • Technology
    • Newborn Immunoassays & Enzymatic Screening Tests
    • Tandem Mass Spectrometry
    • Molecular Assays
    • Newborn Hearing Screening Technologies
    • Pulse Oximetry
    • Other Newborn Screening Technologies (Fluorescence, Gel Electrophoresis, etc.)
  • End User
    • Newborn Screening at Clinical Laboratories
    • Newborn Screening at Hospitals
  • Region
    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • France
      • Spain
      • Italy
      • Rest of Europe
    • East Asia
      • China
      • Japan
      • South Korea
    • South Asia
      • India
      • ASEAN
      • Rest of South Asia
    • Oceania
      • Australia
      • Rest of Oceania
    • Middle East & Africa
      • GCC
      • South Africa
      • Rest of MEA

Full Access of this Report Is Available at https://www.factmr.com/checkout/6323

Competitive Landscape

Prominent newborn screening providers are reliant on such key expansion strategies as product portfolio expansion by virtue of new releases, acquisition of existing manufacturers and entering into strategic agreements and collaborations. These measures help existing providers secure a firm footing in the market.

  • For instance, Bio-Rad Laboratories offers the VARIANTnbs automated newborn screening for sickle cell disease and other hemoglobin disorders, featuring fully automated analysis and advanced result reporting for maximum efficiency. It uses dried blood spot specimens to provide results.
  • Recently, in May 2021, Baebies was awarded US$ 2.7 million in a Phase-II B SBIR grant from the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) which supports validation, clinical evaluation and FDA submission of a rapid test panel for near-patient heparin monitoring.

More Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the newborn screening market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of product (instruments and consumables), test (dry blood spot tests, hearing screening tests, and CCHD screening tests), technology (immunoassays & enzymatic tests, tandem mass spectrometry, molecular assays, hearing screening technologies, pulse oximetry, and others [fluorescence, gel electrophoresis, etc.]), and end user (clinical laboratories and hospitals), across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa).

For More Insights https://www.biospace.com/article/atrial-fibrillation-stroke-treatment-market-players-are-collaborating-with-heart-research-associate-to-offer-enhanced-version-of-medication-says-fact-mr/

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions.We have offices in US and Dublin, whereas our global headquarter is in Dubai.While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.
Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Optimal Daily Doses of Niacin and Niacinamide (Vitamin B3) for Disease Prevention Will Fuel Market Growth – Fact.MR Study

250 Pages Niacin and Niacinamide Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Niacin and Niacinamide to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Niacin and Niacinamide market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=4290

Digital Transformation in Healthcare Presenting Opportunities for Niacin and Niacinamide Market Growth

Healthcare organizations around the world are deploying digital tools to accommodating changing consumer preferences. They are pressing on solving the long-standing challenge pertaining to care model innovation.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the Niacin and Niacinamide market.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Niacin and Niacinamide market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Niacin and Niacinamide

niacin and niacinamide market competation structure

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4290

The report offers actionable and valuable market insights of Niacin and Niacinamide. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Niacin and Niacinamide Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of Niacin and Niacinamide, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Niacin and Niacinamide Market.

Niacin and Niacinamide Market: Segmentation

Fact.MR has studied the niacin and niacinamide market with detailed segmentation on the basis of form, end use, and region.

Form
  • Powder
  • Granular
  • Liquid
End Use
  • Human Nutrition
  • Pharmaceuticals
  • Animal Nutrition
  • Cosmeceuticals
  • Others
Region
  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Middle East & Africa

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/4290

Niacin and Niacinamide Market- Scope of the Report

The recent study by Fact.MR on the niacin and niacinamide market offers a 9-year forecast between 2019 and 2027. The study analyzes crucial trends that are currently determining the growth of the niacin and niacinamide market.

This report explicates on vital dynamics such as drivers, restraints, and opportunities for key market players, along with key stakeholders as well as emerging players associated with the manufacturing of niacin and niacinamide.

The study also provides dynamics that are responsible for influencing the future status of the niacin and niacinamide market over the forecast period.

A detailed assessment of niacin and niacinamide value chain analysis, business execution, and supply chain analysis across regional markets have been covered in the report. A list of prominent companies operating in the niacin and niacinamide market, along with their exhaustive analysis enhance the reliability of this comprehensive research study.

Niacin and Niacinamide Market: Report Summary

The study offers a comprehensive analysis on diverse features including product portfolio, demand, product developments, revenue generation, and sales in the niacin and niacinamide market across the globe.

A comprehensive estimate on the market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of niacin and niacinamide during the forecast period. Price point comparison by region and global average price are also considered in the study.

Niacin and Niacinamide Market: Analysis on Market Size Evaluation

The niacin and niacinamide market has been analyzed for each market segment, in terms of volume (Tons) and value (US $ Mn).

Market estimates at both global and regional levels for niacin and niacinamide are offered in terms of “US$ Mn” for value and in “Tons” for volume. A Y-o-Y growth contrast on prominent market segments, along with the market attractiveness evaluation have been incorporated in the report.

Furthermore, the absolute dollar opportunity analysis of all segments adds to the credibility of the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity and helps to achieve in identifying potential resources, considering sales and distribution perspectives in the global niacin and niacinamide market.

Niacin and Niacinamide Market: Inspected Assessment on Regional Segments

Key sections have been elaborated in the niacin and niacinamide report, which help to deliver projection on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the niacin and niacinamide market during the forecast period.

Country-specific valuation on demand for niacin and niacinamide has been offered for each regional market, along with the market scope estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value and volume for emerging countries has also been included in the report.

Niacin and Niacinamide Market: In-depth Analysis on the Competitive Landscape

The report sheds light on leading manufacturers of the niacin and niacinamide market, along with their detailed profiles. Essential and up-to-date data information related to market performers, who are principally engaged in the production of niacin and niacinamide, have been brought with the help of a detailed dashboard view.

Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which includes various essentials such as product portfolio, key strategies, and an all-inclusive SWOT analysis on each player.

The company presence is mapped and presented through the matrix for all prominent players, thus, providing readers with actionable insights. This helps in thoughtfully presenting market status, and predicting the competition level in the niacin and niacinamide market.

Key Takeaways from Niacin and Niacinamide Market:

  • Animal nutrition accounts for over half of the market revenue due to high demand of niacin in animal nutrition on the premise of limiting medical conditions such as ketosis.
  • Cosmeceuticals application held a nominal share within the niacin and niacinamide market in terms of value. However, with key players exploring newer application areas within the cosmeceutical industry, “Cosmeceuticals” will be the most lucrative application over the long term forecast witnessing a robust CAGR of ~ 7%
  • With more than US$ 50 Bn being invested annually toward oncology R&D, the use of niacin and niacinamide for cancer treatment will provide an upswing to its market
  • MR states that studies over the past half-decade have shown adverse side-effects associated with Niacin & Niacinamide. To mitigate adverse effects, market players including Jubilant Life Sciences Limited, Lonza Group AG etc. are pioneering research efforts to lessen the side effects of niacin.
  • The Asia Pacific Excluding Japan (APEJ) region is expected to rise with the fastest CAGR over the long term forecast period of 2019-2027 due to surging prevalence of lifestyle diseases such as metabolic dysfunction, and obesity

“Rise of health conscious consumers worldwide has resulted in an escalated demand for niacin and nicinamide formulated supplements, pushing market players to align their portfolio and branding as per the market outlook of the chemical,” says Fact.MR analyst.

Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Niacin and Niacinamide Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Niacin and Niacinamide Historical volume analysis: The report provides a comparison of Niacin and Niacinamide’s historical sales and projected sales performance for 2021-2031.
  • Niacin and Niacinamide Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Niacin and Niacinamide market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Niacin and Niacinamide Consumption by demographics: The report investigates consumer behavior affecting Niacin and Niacinamide demand outlook for the assessment period. Effect of their keenness for digital trends on Niacin and Niacinamide market is carefully analyzed
  • Post COVID consumer spending on Niacin and Niacinamide: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Niacin and Niacinamide market growth.

More Valuable Insights on Niacin and Niacinamide Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Niacin and Niacinamide, Sales and Demand of Niacin and Niacinamide, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Estrogen Hormone Replacement Therapy Market to Register 6% CAGR Driven by Growing Prevalence of Diabetes Worldwide – Fact.MR Study

250 Pages Estrogen Hormone Replacement Therapy Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Estrogen Hormone Replacement Therapy to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Estrogen Hormone Replacement Therapy market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=2224

The Estrogen Hormone Replacement Therapy market is foreseen to expand at a significant pace with sales of Estrogen Hormone Replacement Therapy products crossing US$ 12,000 Mn by 2019 end.

Rising incidences of osteoporosis fractures coupled with growing menopause rates among women have remained instrumental in driving the demand for Estrogen Hormone Replacement Therapy. Fact.MR envisages that the demand for Estrogen Hormone Replacement Therapy is projected to expand at a CAGR of 6.0% in terms of value throughout the period of forecast, 2018-2028.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Estrogen Hormone Replacement Therapy market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Estrogen Hormone Replacement Therapy

The report offers actionable and valuable market insights of Estrogen Hormone Replacement Therapy. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Estrogen Hormone Replacement Therapy Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of Estrogen Hormone Replacement Therapy, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Estrogen Hormone Replacement Therapy Market.

Need more information about Report Methodology? Click here-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=2224

Market Structure

The Estrogen Hormone Replacement Therapy market is segmented in detail to cover every angle of the Estrogen Hormone Replacement Therapy space.

The Estrogen Hormone Replacement Therapy market has been segmented on the basis of product type, by dosage form, by indication, by distribution channel and by region.

Various Estrogen Hormone Replacement Therapy products such as estrogen Estrogen Hormone Replacement Therapy, thyroid Estrogen Hormone Replacement Therapy and growth Estrogen Hormone Replacement Therapy is covered.

By dosage form, Estrogen Hormone Replacement Therapy market is segmented into tablets, patches, injections, implants and creams.

By indications, Estrogen Hormone Replacement Therapy market is categorized into menopause, osteoporosis, thyroid and growth hormone deficiency.

By distribution channel, it is segmented by hospital pharmacies, clinics, retail pharmacies and online pharmacies.

The Estrogen Hormone Replacement Therapy market is assessed across key regions such as North America, Latin America, Europe, Asia Pacific excluding Japan (APEJ), Middle East and Africa (MEA) and Japan.

Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/2224

Competitive Landscape

The report on Estrogen Hormone Replacement Therapy market offers intelligence on key participants in the Estrogen Hormone Replacement Therapy market.

The key companies involved in the formulation of Estrogen Hormone Replacement Therapy products are thoroughly assessed and profiled in the report.

Various facets of competition including SWOT analysis, product portfolio analysis, drug developments and innovations, strategies and key financials are covered. Key companies profiled in the report include

  • Novartis AG
  • Novo Nordisk A/S
  • Teva Pharmaceuticals
  • Mylan N.V and Pfizer Inc.

Stakeholders in the Estrogen Hormone Replacement Therapy can find attractive opportunities in developed countries in North America, particularly the United States. According to the American Congress of Obstetricians and Gynecologists, around 6,000 women reach menopause every day, reaching a count of over 2 million annually. This has translated into significant adoption of Estrogen Hormone Replacement Therapy in the country. The demand for Estrogen Hormone Replacement Therapy in the US is also accompanied by higher GDP per capita, triggering high healthcare expenditure.

The report also foresees that the Estrogen Hormone Replacement Therapy market in Asia Pacific excluding Japan (APEJ) region is poised to expand at a relatively higher pace as compared to other regions. According to the report, the APEJ Estrogen Hormone Replacement Therapy market is projected to expand at a stellar pace of 7.2% during the assessment period. This growth can be attributed to increasing population coupled with higher life expectancy in emerging economies such as India and China. Against this backdrop, stakeholders in Estrogen Hormone Replacement Therapy market can expect optimistic growth in the region in the years to follow, leveraging its lucrativeness from an investment standpoint.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Estrogen Hormone Replacement Therapy Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Estrogen Hormone Replacement Therapy Historical volume analysis: The report provides a comparison of Estrogen Hormone Replacement Therapy’s historical sales and projected sales performance for 2021-2031.
  • Estrogen Hormone Replacement Therapy Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Estrogen Hormone Replacement Therapy market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Estrogen Hormone Replacement Therapy Consumption by demographics: The report investigates consumer behavior affecting Estrogen Hormone Replacement Therapy demand outlook for the assessment period. Effect of their keenness for digital trends on Estrogen Hormone Replacement Therapy market is carefully analyzed
  • Post COVID consumer spending on Estrogen Hormone Replacement Therapy: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Estrogen Hormone Replacement Therapy market growth.

More Valuable Insights on Estrogen Hormone Replacement Therapy Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Estrogen Hormone Replacement Therapy, Sales and Demand of Estrogen Hormone Replacement Therapy, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Adoption of Predictive Diagnostic Equipment is Significantly High in US and Europe – Fact.MR Study

250 Pages Predictive Diagnostics Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Predictive Diagnostics to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Predictive Diagnostics market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=5509

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Predictive Diagnostics market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Predictive Diagnostics

The report offers actionable and valuable market insights of Predictive Diagnostics. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Predictive Diagnostics Market across various industries and regions

The healthcare industry is constantly under the pressure of improving patient care while keeping the costs under a certain limit. Predictive diagnostics is one way for healthcare organizations to achieve success at enhanced outcomes at much lower costs.

Need more information about Report Methodology? Click here-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=5509

Key Players

Key players in the global predictive diagnostics market are Abbott Laboratories, Therawis, F.Hoffmann-La Roche Ltd., BIOMÉRIEUX SA, Agilent Technologies, Illumina, Inc., Thermo Fisher Scientific, Inc., Bio-Rad, Myriad Genetics, Inc., Genesis Genetics, Centogene N.V., BGI, 23andMe, Inc., Predictive Oncology, Counsyl, Inc., Bio-Rad Laboratories Inc., Mylab Discovery Solutions Pvt. Ltd., and ARUP Laboratories.

In September 2021, Janssen – a pharmaceutical subsidiary of Johnson & Johnson – announced that it has introduced its nine-month startup accelerator – a program for the digital health startup space to gain innovative ideas on predictive diagnostics to discover precision treatment and therapies.

With this step, the company aims to introduce digital tools to facilitate clinical trials in different disease areas, ultimately to discover treatments at much lower costs.

Through this program, the company will provide selected startups from the Europe, Middle East and Africa (EMEA) region with nine months of support as well as mentorship with members iPEPS – a French brain health incubator – and Janssen.

In October 2021, bioMérieux – a French multinational biotechnology company and a world leader in the area of in-vitro diagnostics – announced that it has launched predictive Diagnostics, which is the company’s new offering in the field of food safety and food quality.

The company’s Predictive Diagnostics offering combines traditional solutions vis-a-vis core microbiology with advanced technologies such as predictive modeling, data sequencing, and data science, declared the global R&D director – Food at bioMérieux.

Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/5509

Key Takeaways

  • Growing adoption of advanced technologies in the healthcare industry indicates the potential for growth in the predictive diagnostics market. By 2031, the global market for predictive diagnostics is expected to surpass the valuation of US$ 3 billion, creating new opportunities for diagnostic tools with high accuracy and precision in the coming decade.
  • The predictive diagnostics market is expected to grow at a CAGR of around 10% between 2021 and 2031. Manufacturers are expected to innovate around the adoption of technologies to predict the risks of various diseases such as cancer, neurological disorders, etc.
  • Based on test types, the adoption of predictive diagnostics based on polymerase chain reaction (PCR) tests is expected to remain high, which manufacturers are slowly moving towards next-generation sequencing (NGS) platforms by integrating advanced technologies in their tools.
  • With the growing demand for predictive diagnostic tools for identifying the risks of various types of cancer, manufacturers in the predictive diagnostics market are upscaling the production and research & development effort to discover accurate predictive tests for cancer.
  • The demand for predictive diagnostics is expected to remain significantly high in developed regions, especially in North America. Growing presence of market leaders and increasing healthcare spending in the United States makes the region a profitable market for manufacturers and other stakeholders.

“Personalized treatments and precision medicines are among the top, fast-growing trends in the healthcare industry, and these are the salient factors that are contributing to the growth of the predictive diagnostics market. Doctors, physicians, pathologists among all the other healthcare service providers are making a move towards diagnostic tools that can offer maximum reliability to incur positive medical outcomes at a lower cost. This fortifies the role of technology and innovation in the predictive diagnostics market. In the coming years, Manufacturers in the predictive diagnostics market must benefit from this trend by increasing awareness in the healthcare domains of developing economies,” says a lead analyst at Fact.MR.

Predictive Diagnostics for Breast and Ovarian Cancer – A Key Trend

The incidence of genetically transferred cancer types such as breast cancer and ovarian cancer has increased dramatically in the past few years. According to the World Cancer Research Fund, over 2 million new cases of breast cancer and more than 300,000 new cases of ovarian cancer were recorded across the world in 2018.

Also, cancer is one of the leading causes of death, which makes it important for healthcare providers to use high-tech predictive diagnostics to identify risks of cancer in individuals. This is one of the key factors that are likely to trigger this trend in the predictive diagnostics market.

Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Predictive Diagnostics Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Predictive Diagnostics Historical volume analysis: The report provides a comparison of Predictive Diagnostics’s historical sales and projected sales performance for 2021-2031.
  • Predictive Diagnostics Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Predictive Diagnostics market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Predictive Diagnostics Consumption by demographics: The report investigates consumer behavior affecting Predictive Diagnostics demand outlook for the assessment period. Effect of their keenness for digital trends on Predictive Diagnostics market is carefully analyzed
  • Post COVID consumer spending on Predictive Diagnostics: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Predictive Diagnostics market growth.

More Valuable Insights on Predictive Diagnostics Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Predictive Diagnostics, Sales and Demand of Predictive Diagnostics, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Why is the U.S Experiencing High Demand for Lung Cancer Treatment – Exclusive Report by Fact.MR

250 Pages Lung Cancer Treatment Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Lung Cancer Treatment to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Lung Cancer Treatment market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=49 

A newly published report by Fact.MR estimates the global Lung Cancer Treatment market revenue to reach US$ 4 Bn by 2031, representing a 2x increase from 2020. Augmented development of lung cancer-specific biomarkers is propelling demand for the Lung Cancer Treatment over the forecast period. Revenue from CA tests will account for US$ 1 Bn by 2031-end.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Lung Cancer Treatment market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Lung Cancer Treatment

The report offers actionable and valuable market insights of Lung Cancer Treatment. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Lung Cancer Treatment Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of Lung Cancer Treatment, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Lung Cancer Treatment Market.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=49 

Segmentation:

  • Test Type

    • CA Test for Lung Cancer Treatment
    • HER2 Tests for Lung Cancer Treatment
    • ALK Tests for Lung Cancer Treatment
    • Angiogenesis Inhibitor for Lung Cancer Treatment
    • EGFR Mutation Tests for Lung Cancer Treatment
    • KRAS Mutation Tests for Lung Cancer Treatment
    • Others

  • End-User

    • Lung Cancer Treatment  for Hospital Associated Labs
    • Lung Cancer Treatment for Independent Diagnostic Laboratories
    • Lung Cancer Treatment for Cancer Research Institutes
    • Others

  • Indication

    • Non-Small-cell Lung Cancer Treatment
    • Small-cell Lung Cancer Treatment

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/49 

Key Takeaways from Market Study

  • By test type, CA lung cancer diagnostic tests to reign supreme, clocking US$ 1 Bn by 2031
  • Hospital-associated labs set to reach around US$ 1.6 Bn until 2031
  • Treatment for non-small cell lung cancer (NSCLC) to comprise over 50% of total demand
  • Cancer research institutes to make significant use of Lung Cancer Treatment, expanding at 6% CAGR
  • Angiogenesis inhibitors is the fastest growing segment followed by HER2 tests
  • U.S to acquire around 27% market share in the global Lung Cancer Treatment industry
  • China is expected to register a CAGR of around 8% until 2031, with NSCLC treatment gaining traction

“Rapid technological advancements with respect to human diagnostics is prompting Lung Cancer Treatment service providers to leverage key advancements, including AI and automation, opening lucrative growth frontiers,” comments a Fact.MR analyst.

Competitive Landscape

Prominent players are embracing innovative approaches such as ground-breaking marketing tactics, technological advances for cancer screening, mergers, and acquisitions.

  • In March 2021, Next-generation sequencing (NGS)-based precision oncology provider Geneseeq Technology Inc. collaborated with Illumina, Inc. (to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer, using Illumina’s NextSeq™ 550Dx sequencing platform.
  • In Jan 2017, Abbott Laboratories completed largest the acquisition of St.Jude Medical for US$ 25 Bn. Together, the company will compete in nearly every area of the $30 billion cardiovascular markets and hold the No. 1 or 2 positions across large and high-growth cardiovascular device markets.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Lung Cancer Treatment Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Lung Cancer Treatment Historical volume analysis: The report provides a comparison of Lung Cancer Treatment’s historical sales and projected sales performance for 2021-2031.
  • Lung Cancer Treatment Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Lung Cancer Treatment market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Lung Cancer Treatment Consumption by demographics: The report investigates consumer behavior affecting Lung Cancer Treatment demand outlook for the assessment period. Effect of their keenness for digital trends on Lung Cancer Treatment market is carefully analyzed
  • Post COVID consumer spending on Lung Cancer Treatment: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Lung Cancer Treatment market growth.

More Valuable Insights on Lung Cancer Treatment Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Lung Cancer Treatment, Sales and Demand of Lung Cancer Treatment, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

North America’s Dominance in the Global Gas Chromatography Detectors Market will Remain Unchallenged through 2031 – Fact.MR Survey

250 Pages Gas Chromatography Detectors Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Gas Chromatography Detectors to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Gas Chromatography Detectors market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=193 

Gas Chromatography Detectors (GC) is used for analysis and separation of compounds, which are capable of vaporizing without undergoing decomposition. GC is used for testing purity of substances, separating the components in a mixture. Gas Chromatography Detectors is also being used for preparing pure compounds from mixtures, and identifying the compounds.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Gas Chromatography Detectors market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Gas Chromatography Detectors

The report offers actionable and valuable market insights of Gas Chromatography Detectors. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Gas Chromatography Detectors Market across various industries and regions

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=193

Market Taxonomy

Product
  • Instruments
  • Detectors
  • Auto-Samplers
  • Fraction Collectors
  • Accessories & Consumables
End User
  • Pharmaceutical & Biotechnology Industries
  • Food & Beverage Industry
  • Oil & Gas Industry
  • Academic Research Institutes
  • Others

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/193

Competition Tracking

Key market players listed in Fact.MR’s report include

  • Agilent Technologies
  • DANI Instruments S.p.A
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Restek Corporation
  • Shimadzu Corporation
  • LECO Corporation
  • Perkin Elmer Inc.
  • Danaher Corporation.

6 Key Projections on Future of Global Gas Chromatography Detectors Market

  1. Auto-samplers, and accessories & consumables will emerge as the fastest-selling products in the market, with auto-samplers being more lucrative than the accessories & consumables, in terms of revenues.
  2. Gas Chromatography Detectors instruments will remain the most lucrative product, with sales estimated to surpass US$ 1,600 Mn in revenues by 2022-end.
  3. Oil & gas industries will continue to be the largest end-users in the global Gas Chromatography Detectors market. In addition, revenues from pharmaceutical & biotechnology industries, and oil & gas industries will hold approximately two-third market share during 2017 to 2022.
  4. North America will retain its dominance in the global Gas Chromatography Detectors market, with sales exhibiting an impressive expansion through 2022. United States is becoming well known for its biopharmaceutical research, and the production of pharmaceutical drugs. Geriatric population in North America has been surging, which in turn is driving demand for medicines to treat various diseases. These factors will propel growth of the market in North America.
  5. Europe will continue to be the second largest market for Gas Chromatography Detectors throughout the forecast period.
  6. Key players listed in Fact.MR’s report on the global Gas Chromatography Detectors market include Danaher Corporation, Perkin Elmer Inc., LECO Corporation, Shimadzu Corporation, Restek Corporation, Merck KGaA, Thermo Fisher Scientific, Inc., DANI Instruments S.p.A, and Agilent Technologies.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Gas Chromatography Detectors Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Gas Chromatography Detectors Historical volume analysis: The report provides a comparison of Gas Chromatography Detectors’s historical sales and projected sales performance for 2021-2031.
  • Gas Chromatography Detectors Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Gas Chromatography Detectors market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Gas Chromatography Detectors Consumption by demographics: The report investigates consumer behavior affecting Gas Chromatography Detectors demand outlook for the assessment period. Effect of their keenness for digital trends on Gas Chromatography Detectors market is carefully analyzed
  • Post COVID consumer spending on Gas Chromatography Detectors: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Gas Chromatography Detectors market growth.

More Valuable Insights on Gas Chromatography Detectors Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Gas Chromatography Detectors, Sales and Demand of Gas Chromatography Detectors, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates